2-206445453-A-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000264377.8(ADAM23):āc.361A>Cā(p.Ile121Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000802 in 1,614,188 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000264377.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAM23 | NM_003812.4 | c.361A>C | p.Ile121Leu | missense_variant | 2/26 | ENST00000264377.8 | NP_003803.1 | |
ADAM23 | NM_001410985.1 | c.361A>C | p.Ile121Leu | missense_variant | 2/26 | NP_001397914.1 | ||
ADAM23 | XM_005246932.4 | c.361A>C | p.Ile121Leu | missense_variant | 2/25 | XP_005246989.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAM23 | ENST00000264377.8 | c.361A>C | p.Ile121Leu | missense_variant | 2/26 | 1 | NM_003812.4 | ENSP00000264377 | P4 | |
ADAM23 | ENST00000374415.7 | c.361A>C | p.Ile121Leu | missense_variant | 2/26 | 5 | ENSP00000363536 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000394 AC: 60AN: 152222Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000505 AC: 127AN: 251342Hom.: 0 AF XY: 0.000486 AC XY: 66AN XY: 135852
GnomAD4 exome AF: 0.000845 AC: 1235AN: 1461848Hom.: 1 Cov.: 31 AF XY: 0.000817 AC XY: 594AN XY: 727222
GnomAD4 genome AF: 0.000394 AC: 60AN: 152340Hom.: 0 Cov.: 32 AF XY: 0.000403 AC XY: 30AN XY: 74486
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2021 | The c.361A>C (p.I121L) alteration is located in exon 2 (coding exon 2) of the ADAM23 gene. This alteration results from a A to C substitution at nucleotide position 361, causing the isoleucine (I) at amino acid position 121 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at